Hypertrophic obstructive cardiomyopathy has the potential to lead to sudden death, heart failure, and is generally more severe and can usually be treated with medication and surgery.
Hypertrophic obstructive cardiomyopathy is a disease of abnormal contractile function of the heart muscle, characterized by thickening of the left ventricular wall and impaired diastolic function. It is often associated with genetic and endocrine factors, and most patients present with symptoms such as dyspnea, chest pain, panic, and fatigue. Hypertrophic obstructive cardiomyopathy, which carries the risk of causing sudden death and the possibility of causing heart failure, is generally more serious.
Drug therapy for patients with hypertrophic obstructive cardiomyopathy includes beta-blockers such as metoprolol tablets and bisoprolol tablets, which are able to reduce myocardial oxygen consumption, and calcium channel blockers such as verapamil and diltiazem to attenuate myocardial contraction, and surgical treatments such as ventricular septal myocardial resection can be considered in severe cases.
If the patient is diagnosed with hypertrophic obstructive cardiomyopathy, it is recommended to go to the hospital and follow the doctor’s instructions for early and aggressive treatment.